The partnership includes all of Folium’s bulk ingredients and finished products. The firms will also jointly develop new delivery systems and applications for cannabinoids.
Photo © Shutterstock.com/ElRoi
Van Drunen Family of Companies (Momence, IL) and Folium Biosciences (Colorado Springs, CO) have entered into a strategic partnership in which the sister companies Van Drunen Farms and FutureCeuticals will be the exclusive distributors of Folium products in the food, beverage, and supplements category around the world. Folium is a global producer, manufacturer, and distributor of broad-spectrum hemp-derived cannabinoids.
"This partnership is a validation of our unwavering commitment to quality, science, scale, and innovation. It positions Folium, Van Drunen Farms and FutureCeuticals as global leaders in the most in-demand consumer product," said Kashif Shan, CEO and co-founder of Folium Biosciences, in a press release. "FutureCeuticals and Van Drunen Farms have always been at the forefront of innovative scientific development and quality in their respective marketplaces, so the fact that this well-established industry leader has chosen to make a serious commitment to us and the global distribution of CBD products heralds what we believe to be an exponential adoption of non-psychoactive cannabinoids worldwide.”
The partnership includes all of Folium’s bulk ingredients and finished products. The firms will also jointly develop new delivery systems and applications for cannabinoids. "We couldn't be more excited about our alliance with Folium," said Brad Evers, vice president of sales for Van Drunen Farms and FutureCeuticals, in a press release. "We have been patiently observing the industry waiting for the right company to partner with on CBD. After extensive discussions with Kashif and the team at Folium, we became convinced that combining our respective expertise was a singular opportunity to move the market and deliver on, and ultimately define, the promise of CBD-based products for years to come.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.